These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
197 related articles for article (PubMed ID: 15902842)
1. Role of endothelin in fibrosis and anti-fibrotic potential of bosentan. Clozel M; Salloukh H Ann Med; 2005; 37(1):2-12. PubMed ID: 15902842 [TBL] [Abstract][Full Text] [Related]
2. Bosentan reverses the pro-fibrotic phenotype of systemic sclerosis dermal fibroblasts via increasing DNA binding ability of transcription factor Fli1. Akamata K; Asano Y; Aozasa N; Noda S; Taniguchi T; Takahashi T; Ichimura Y; Toyama T; Sato S Arthritis Res Ther; 2014 Apr; 16(2):R86. PubMed ID: 24708674 [TBL] [Abstract][Full Text] [Related]
3. Endothelin-1 is involved in norepinephrine-induced ventricular hypertrophy in vivo. Acute effects of bosentan, an orally active, mixed endothelin ETA and ETB receptor antagonist. Kaddoura S; Firth JD; Boheler KR; Sugden PH; Poole-Wilson PA Circulation; 1996 Jun; 93(11):2068-79. PubMed ID: 8640984 [TBL] [Abstract][Full Text] [Related]
4. Both ETA and ETB receptors mediate contraction to endothelin-1 in human blood vessels. Seo B; Oemar BS; Siebenmann R; von Segesser L; Lüscher TF Circulation; 1994 Mar; 89(3):1203-8. PubMed ID: 8124808 [TBL] [Abstract][Full Text] [Related]
6. Endogenous endothelin-1 signaling contributes to type I collagen and CCN2 overexpression in fibrotic fibroblasts. Shi-Wen X; Renzoni EA; Kennedy L; Howat S; Chen Y; Pearson JD; Bou-Gharios G; Dashwood MR; du Bois RM; Black CM; Denton CP; Abraham DJ; Leask A Matrix Biol; 2007 Oct; 26(8):625-32. PubMed ID: 17681742 [TBL] [Abstract][Full Text] [Related]
7. Bosentan antagonizes the effects of endothelin-1 on rat gastric blood flow and mucosal integrity. Lazaratos S; Nakahara A; Goto K; Fukutomi H Life Sci; 1995; 56(9):PL195-200. PubMed ID: 7869843 [TBL] [Abstract][Full Text] [Related]
8. [The pharmacology of endothelin and its antagonist bosentan]. Clozel M; Roux S Ann Endocrinol (Paris); 2000 Feb; 61(1):75-9. PubMed ID: 10790596 [TBL] [Abstract][Full Text] [Related]
9. Bosentan and the endothelin system in congestive heart failure. Ellahham SH; Charlon V; Abassi Z; Calis KA; Choucair WK Clin Cardiol; 2000 Nov; 23(11):803-7. PubMed ID: 11097125 [TBL] [Abstract][Full Text] [Related]
10. Endothelin antagonism with bosentan: current status and future perspectives. Ono K; Matsumori A Cardiovasc Drug Rev; 2002; 20(1):1-18. PubMed ID: 12070530 [TBL] [Abstract][Full Text] [Related]
11. Role of endothelin in the maintenance of blood pressure in conscious rats with chronic heart failure. Acute effects of the endothelin receptor antagonist Ro 47-0203 (bosentan). Teerlink JR; Löffler BM; Hess P; Maire JP; Clozel M; Clozel JP Circulation; 1994 Nov; 90(5):2510-8. PubMed ID: 7955209 [TBL] [Abstract][Full Text] [Related]
12. Effects of bosentan on cellular processes involved in pulmonary arterial hypertension: do they explain the long-term benefit? Clozel M Ann Med; 2003; 35(8):605-13. PubMed ID: 14708970 [TBL] [Abstract][Full Text] [Related]
13. Synergistic growth inhibitory effects of the dual endothelin-1 receptor antagonist bosentan on pancreatic stellate and cancer cells. Fitzner B; Brock P; Holzhüter SA; Nizze H; Sparmann G; Emmrich J; Liebe S; Jaster R Dig Dis Sci; 2009 Feb; 54(2):309-20. PubMed ID: 18612819 [TBL] [Abstract][Full Text] [Related]
14. ETA and ETB receptors mediate contraction to endothelin-1 in renal artery of aging SHR. Effects of FR139317 and bosentan. Seo B; Lüscher TF Hypertension; 1995 Apr; 25(4 Pt 1):501-6. PubMed ID: 7721390 [TBL] [Abstract][Full Text] [Related]
15. Endothelin plays a role in the maintenance of blood pressure in normotensive guinea pigs. Véniant M; Clozel JP; Hess P; Clozel M Life Sci; 1994; 55(6):445-54. PubMed ID: 8035662 [TBL] [Abstract][Full Text] [Related]
16. Identification of a region of the human endothelin ETA receptor required for interaction with bosentan. Adachi M; Furuichi Y; Miyamoto C Eur J Pharmacol; 1994 Oct; 269(2):225-34. PubMed ID: 7851498 [TBL] [Abstract][Full Text] [Related]
17. Constitutive ALK5-independent c-Jun N-terminal kinase activation contributes to endothelin-1 overexpression in pulmonary fibrosis: evidence of an autocrine endothelin loop operating through the endothelin A and B receptors. Shi-Wen X; Rodríguez-Pascual F; Lamas S; Holmes A; Howat S; Pearson JD; Dashwood MR; du Bois RM; Denton CP; Black CM; Abraham DJ; Leask A Mol Cell Biol; 2006 Jul; 26(14):5518-27. PubMed ID: 16809784 [TBL] [Abstract][Full Text] [Related]
18. Endothelin B receptor-mediated vasoconstriction induced by endothelin A receptor antagonist. Zhang Y; Oliver JR; Horowitz JD Cardiovasc Res; 1998 Sep; 39(3):665-73. PubMed ID: 9861310 [TBL] [Abstract][Full Text] [Related]
19. Endothelin in the pulmonary circulation with special reference to hypoxic pulmonary vasoconstriction. Holm P Scand Cardiovasc J Suppl; 1997; 46():1-40. PubMed ID: 9265559 [TBL] [Abstract][Full Text] [Related]